These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2870086

  • 21. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M, Shah S, Ramkisson R, Murphy S, Zaman R.
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [Abstract] [Full Text] [Related]

  • 22. Risks versus benefits of different types of long-acting injectable antipsychotics.
    McEvoy JP.
    J Clin Psychiatry; 2006 Jun; 67 Suppl 5():15-8. PubMed ID: 16822092
    [Abstract] [Full Text] [Related]

  • 23. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Jun; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 24. Integrating non-drug treatments in early schizophrenia.
    Lewis SW, Tarrier N, Drake RJ.
    Br J Psychiatry Suppl; 2005 Aug; 48():s65-71. PubMed ID: 16055811
    [Abstract] [Full Text] [Related]

  • 25. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G, Huber G, Schüttler R.
    Psychiatr Clin (Basel); 1980 Aug; 13(3-4):179-92. PubMed ID: 6113621
    [Abstract] [Full Text] [Related]

  • 26. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR, Lehtinen K, Aaltonen J, Räkköläinen V, Syvälahti E, Lehtinen V.
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [Abstract] [Full Text] [Related]

  • 27. Family management in the prevention of exacerbations of schizophrenia: a controlled study.
    Falloon IR, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM.
    N Engl J Med; 1982 Jun 17; 306(24):1437-40. PubMed ID: 6123079
    [Abstract] [Full Text] [Related]

  • 28. Early, targeted pharmacotherapeutic intervention in schizophrenia.
    Carpenter W.
    J Clin Psychiatry; 1986 May 17; 47 Suppl():23-9. PubMed ID: 2871012
    [Abstract] [Full Text] [Related]

  • 29. Psychosocial treatments for bipolar disorders.
    Scott J, Colom F.
    Psychiatr Clin North Am; 2005 Jun 17; 28(2):371-84. PubMed ID: 15826737
    [Abstract] [Full Text] [Related]

  • 30. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
    Kane JM.
    J Clin Psychiatry; 2003 Jun 17; 64 Suppl 16():34-40. PubMed ID: 14680417
    [Abstract] [Full Text] [Related]

  • 31. Medication and psychotherapy in the treatment of chronic schizophrenia.
    Sarti P, Cournos F.
    Psychiatr Clin North Am; 1990 Jun 17; 13(2):215-28. PubMed ID: 1972273
    [Abstract] [Full Text] [Related]

  • 32. The long-term outcome of 2 family intervention strategies in schizophrenia.
    Montero I, Masanet MJ, Bellver F, Lacruz M.
    Compr Psychiatry; 2006 Jun 17; 47(5):362-7. PubMed ID: 16905398
    [Abstract] [Full Text] [Related]

  • 33. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct 17; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 34. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A, Goudemand M, Thomas P.
    Encephale; 2009 Feb 17; 35(1):80-9. PubMed ID: 19250998
    [Abstract] [Full Text] [Related]

  • 35. A group approach to psychopharmacology with schizophrenics.
    Skolnick MR.
    Yale J Biol Med; 1985 Feb 17; 58(4):317-26. PubMed ID: 2864762
    [Abstract] [Full Text] [Related]

  • 36. Working with the families of schizophrenic patients.
    Leff J.
    Br J Psychiatry Suppl; 1994 Apr 17; (23):71-6. PubMed ID: 7913611
    [Abstract] [Full Text] [Related]

  • 37. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E.
    Br J Psychiatry Suppl; 1996 Dec 17; (31):41-51. PubMed ID: 8968654
    [No Abstract] [Full Text] [Related]

  • 38. Behavioral rehabilitation for chronic mental patients.
    Liberman RP, Evans CC.
    J Clin Psychopharmacol; 1985 Jun 17; 5(3 Suppl):8S-14S. PubMed ID: 2860141
    [Abstract] [Full Text] [Related]

  • 39. [Strategies of long-term medication in schizophrenia].
    Gaebel W.
    Fortschr Neurol Psychiatr; 2001 Sep 17; 69 Suppl 2():S113-9. PubMed ID: 11533861
    [Abstract] [Full Text] [Related]

  • 40. Current status of family intervention science.
    Diamond G, Siqueland L.
    Child Adolesc Psychiatr Clin N Am; 2001 Jul 17; 10(3):641-61. PubMed ID: 11449817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.